Cadence Pharmaceuticals, Inc. (NASDAQ:CADX)
CAPS Rating:
A biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.
A biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.
Recs
T$x Up & Buy